Journal profile · Multiple
Materials Today Bio
ISSN 2590-0064 · ELSEVIER · ENGLAND
Materials Today Bio: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11; fully open access; APC about USD 3,290; median 105 days to acceptance (141 articles, last 24 months); 1,296 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Materials Today Bio is published by ELSEVIER and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Nanoplatforms for cancer theranostics, Bone Tissue Engineering Materials and 3D Printing in Biomedical Research, together about 32.6% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Materials Today Bio is a multidisciplinary journal focused on the interface between biology and materials science, chemistry, physics, engineering, and medicine. From the design and assembly of novel structures, their functionalization and interaction with biological systems to bioimaging, therapies and diagnostics in healthcare, the journal will capture the most exciting advances and discoveries within this field.Part of the Materials Today Family of journals, Materials Today Bio offers authors rigorous peer review, rapid decisions, and high visibility. The editors welcome comprehensive articles, short communications and reviews on topics including but not limited to:• Biomaterials • Tissue Engineering and Regenerative Medicine • Cell encapsulation and cell engineering • Biomolecular and biomacromolecular Engineering • Biofabrication • Biohybrid Materials • Nanomedicine and bionanotechnology • Biosensors including BioMEMS, BioNEMS • Lab-on-a chip and organ-on-a chip • Actuators and soft/bioelectronics • Bioimaging and diagnosis • In vitro biological models • Hydrogels • Drug and gene delivery • Biopolymers • Bioinspired surfaces and interfaces • Living Materials • Synthetic biology • Micro and nanofluidics for bioengineering or biological sciences • Responsive and adaptive systems • Modelling and simulation of biological systems with reference to experimental results • Bio-based materialsMaterials Today Bio sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Biomaterials Advances and Biomaterials and Biosystems.The Materials Today Family of journals provides authors and readers with comprehensive coverage of all materials science disciplines – from incremental results to ground-breaking discoveries. Our journals offer multi- and inter-disciplinary platforms for collaboration and the cross-pollination of ideas to drive the field forward.If you have high-quality research that has the potential to make a real impact, advancing scientific knowledge and fuelling innovation, we’d like to hear from you.Find out more
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief João ManoPublisher website
Editorial board by country: 33 in mainland China (about 35%); most named Mainland China 33, United States 14, Portugal 8, United Kingdom 6, Australia 6 (94 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoplatforms for cancer theranosticsEngineering15.8%
- Bone Tissue Engineering MaterialsEngineering8.8%
- 3D Printing in Biomedical ResearchEngineering8%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science6.2%
- Nanoparticle-Based Drug DeliveryMaterials Science5.8%
- Wound Healing and TreatmentsMedicine5.2%
- Tissue Engineering and Regenerative MedicineMedicine4.8%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 1 |
| Minor | Engineering, Biomedical | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 2 |
| Minor | Materials Science, Biomaterials | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11LetPub ·
- Impact factor (publisher)
- 11Publisher website ·
- CiteScore 2026-06
- 12LetPub ·
- CiteScore (publisher)
- 12Publisher website ·
- SJR 2026-06
- 1.89LetPub ·
- SNIP 2026-06
- 1.5LetPub ·
- h-index
- 92OpenAlex ·
- i10-index
- 1,377OpenAlex ·
- 2-year mean citedness
- 6.37OpenAlex ·
- Self-citation rate
- 5.5%LetPub ·
- Share of gold OA articles
- 99.95%LetPub ·
Volume
- Articles per year
- 1,208LetPub ·
Articles by year OpenAlex count · 3,648 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 956 | 956 | 728 |
| 2025 | 1,296 | 1,296 | 9,194 |
| 2024 | 492 | 492 | 7,564 |
| 2023 | 395 | 395 | 12,708 |
| 2022 | 327 | 327 | 13,726 |
| 2021 | 103 | 103 | 5,222 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
105 daysMedian, submission to acceptance · P25–P75 73 days – 145 days
- Acceptance to online
- median 1 days (141 articles)
- Submission to online
- median 106 days
- Sample
- 141 articles with submission and acceptance dates (2,400 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 29 daysPublisher website ·
- Submission to acceptance
- 79 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,290 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,400 / EUR 3,180 / GBP 2,720 / JPY 421,700 | — | — | |
| LetPub | USD 3,150 | Yes | — | |
| Publisher website | USD 3,290 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
Publisher websiteWhat to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Highlights
- Optional
- Cover letter
- Required
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access journal Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- ELSEVIER
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2590-0064
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Materials Today Bio
What CAS zone is Materials Today Bio in?
In the 2025 upgraded edition of the CAS Journal Ranking, Materials Today Bio is in Zone 1 of Medicine, and in Zone 1 of the minor category Materials Science, Biomaterials / Engineering, Biomedical; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Materials Today Bio?
The latest impact factor listed by LetPub is 11; CiteScore 12, h-index 92.
How long does peer review take at Materials Today Bio?
Based on the dates recorded on 141 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 105 days (interquartile range 73–145 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Materials Today Bio?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Highlights: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Materials Today Bio based?
Of the 94 board members whose country the journal's board page names, 33 (about 35%) are in mainland China; the countries named most often are Mainland China (33), United States (14) and Portugal (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Materials Today Bio?
According to LetPub and DOAJ records, Materials Today Bio is indexed in SCIE, Scopus and DOAJ.
Is Materials Today Bio open access, and what is the APC?
Materials Today Bio is a fully open-access journal. APC about USD 3,290.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .